Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group

Affiliations

• ¹ Division of Hematology, Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA.
• ² Incyte Corporation, Wilmington, DE, USA.
• ³ ARUP Laboratories and University of Utah School of Medicine, Salt Lake City, UT, USA.
• ⁴ Hôpital Saint-Louis, Paris, France.
• ⁵ Universitätsmedizin Mannheim, Mannheim, Germany.
• ⁶ University of Florence, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
• ⁷ Division of Hematology, Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA. Jason.gotlib@stanford.edu.